Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've been researching semaglutide and come across the phrase "pre-filled syringe", you might be wondering whether you'll need to draw up a dose yourself. The short answer: Wegovy, the semaglutide medicine licensed in the UK for weight management, is supplied as a pre-filled injection pen, not a traditional syringe. Each pen comes ready to use, with no measuring or loading required. Because semaglutide is a prescription-only medicine, a prescriber assesses your suitability before any treatment is supplied. If you'd like to understand what the device actually looks like, how it differs from what you might have pictured, and what the clinical evidence says about how it works, this page covers it thoroughly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Plenty of people searching for a semaglutide pre-filled syringe have the same image in mind: a glass barrel, a rubber plunger, a separately attached needle. It's a natural mental picture, especially if you've seen images of insulin delivery. Wegovy doesn't work like that. It arrives as an auto-injector pen, sealed and pre-loaded at the factory, with the dose already set. You don't handle the liquid directly. You don't measure anything. You click the pen against your skin, press the button, and the device does the rest.
Each pen contains four weekly doses at the same strength, meaning one pen covers a full four-week period. The Wegovy injection pen has a fine, short needle that most users describe as barely noticeable. Injection sites rotate across the abdomen, outer thigh and upper arm. The Patient Information Leaflet that comes with your medication walks through the exact technique step by step, and our prescribers are available through aftercare if anything feels unclear.
The device design matters practically. Because it's pre-filled and pre-set, there's no risk of drawing up the wrong volume, and no need to source separate needles or syringes. If you've been reading about which syringe to use for semaglutide, that question applies mainly to compounded or unlicensed preparations that aren't dispensed by regulated UK pharmacies, not to licensed Wegovy pens. Our guide to the semaglutide prefilled syringe explains how that format differs from the auto-injector pen you receive when prescribed Wegovy through a licensed UK pharmacy.
Semaglutide is a GLP-1 receptor agonist, meaning it mimics a gut hormone your body already produces after eating. When that hormone is present at higher, sustained levels, several things happen in combination. The brain receives signals that reduce appetite. The stomach empties more slowly, so food sits there longer and fullness arrives earlier. Over weeks, many people find their relationship with food shifts noticeably, cravings quieten, portion sizes naturally fall.
Unlike tirzepatide (which acts on two receptors), semaglutide targets one. That distinction matters when comparing options. Our semaglutide overview goes deeper on how the mechanism translates into real-world results for different people.
In the STEP 1 clinical trial, adults using semaglutide 2.4mg alongside lifestyle changes achieved an average body-weight reduction of around 15% over 68 weeks, compared with around 2.4% for placebo, as published in the New England Journal of Medicine. The MHRA subsequently approved a 7.2mg dose, with early trial data suggesting average weight loss approaching 20.7%, the MHRA's April 2026 announcement covers the detail. Higher doses narrow the gap with tirzepatide considerably, though which medicine suits a particular person is a clinical question, not one an article can answer.
The semaglutide injection is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The licence covers weight management alongside a reduced-calorie diet and increased physical activity, the medicine works best when those elements are present, and our clinical team will talk through realistic expectations at consultation.
Semaglutide is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It's also not licensed for people under 18. Certain conditions, including a personal or family history of medullary thyroid carcinoma, require prescriber discussion before treatment begins. The NHS semaglutide medicines page lists the full set of contraindications in plain English and is worth reading before your consultation.
One question our prescribers field regularly is about timing, specifically, whether there's flexibility in the day of the week. The answer depends on the clinical picture; our page on taking your Wegovy shot a day early covers what guidance says about this.
The only legal route to Wegovy in the UK is through a prescription following a clinical assessment. That assessment checks your medical history, current medicines, weight, and any conditions that might affect suitability. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, a real clinician reads your answers, not software. Orders placed before 12pm on a working day are dispatched the same day once clinically approved, arriving free the next working day by tracked DPD in plain packaging.
If you want to compare the full range of options available, the weight-loss treatments page sets out what's currently dispensed and how the process works. For a broader look at the landscape, our weight-loss overview explains how medicines fit alongside lifestyle changes. Thinking about buying online? Our page on buying Wegovy online explains what to check before you do, including how to verify any pharmacy on the GPhC register.
On cost: private semaglutide treatment varies between providers and by dose, and legitimate pricing always reflects the prescription and clinical review it includes. We're deliberately not the cheapest option available. One transparent price covers consultation, prescription, delivery and aftercare, with no subscription. If you'd like to understand more about what drives pricing across the market, our FAQs address that directly. When you're ready, start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.